IgG4-related disease
Showing 1 - 25 of >10,000
Diagnostic and Prognostic Biomarkers for IgG4-related Disease.
Recruiting
- Immunoglobulin G4-Related Disease
- blood test
-
Barcelona, SpainHospital de la Santa Creu i Sant Pau
Jun 12, 2023
IgG4 Related Disease Trial (CM310)
Not yet recruiting
- IgG4 Related Disease
- CM310
- (no location specified)
Feb 13, 2023
Tofatib Treatment for IgG4-related Disease
Recruiting
- IgG4-related Disease
-
Shanghai, Shanghai, ChinaShanghai Changhai Hospital
Nov 15, 2022
COVID-19 on Clinical Outcomes and Management of IgG4 Related
Active, not recruiting
- IgG4 Related Disease
- Covid19
- exposure to COVID19
-
Sha Tin, New Territories, Hong KongPrince of Wales Hospital, The Chinese University of Hong Kong
Nov 18, 2022
IgG4-related Disease With Eosinophilia Trial in Beijing (Prednisolone, Baricitinib)
Recruiting
- IgG4-related Disease With Eosinophilia
-
Beijing, Bejing, ChinaPeking Union Medical College Hospital
Mar 23, 2023
Autoimmune Diseases Trial in Beijing (, mycophenolate mofetil)
Not yet recruiting
- Autoimmune Diseases
- placebo
- mycophenolate mofetil
-
Beijing, ChinaPeking Union Medical College Hospital
Jul 26, 2023
Detecting IgG4-related Sclerosing Cholangitis
Completed
- IgG4-related Sclerosing Cholangitis
- IgG4-related Disease
-
Rochester, Minnesota
- +1 more
Jan 3, 2022
Autoimmune Diseases Trial in Beijing (Drug free, IS monotherapy and GC combined with IS)
Recruiting
- Autoimmune Diseases
- Drug free, IS monotherapy and GC combined with IS
-
Beijing, Beijing, ChinaBeijing Friendship Hospital
Jan 21, 2022
IgG4-related Disease Trial in Boston (Abatacept)
Completed
- IgG4-related Disease
-
Boston, MassachusettsMassachusetts General Hospital
Jul 30, 2021
IgG4-related Disease Trial in Beijing (Prednisone and Belimumab, Prednisone)
Recruiting
- IgG4-related Disease
- Prednisone and Belimumab
- Prednisone
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jan 6, 2021
IgG4-related Disease Trial in Beijing (68Ga-FAPI)
Recruiting
- IgG4-related Disease
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jan 24, 2021
Plasmablast/Plasma Cells in Diagnosis of IgG4-RD, Plasmablast/Plasma Cells in Relapse Prediction of IgG4-RD Trial in Beijing
Unknown status
- Plasmablast/Plasma Cells in Diagnosis of IgG4-RD
- Plasmablast/Plasma Cells in Relapse Prediction of IgG4-RD
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Sep 1, 2020
Multicenter Observational Study of PSC and IgG4-SC in China
Recruiting
- Primary Sclerosing Cholangitis
- IgG4-related Sclerosing Cholangitis
- Only observation
-
Shanghai, 上海市, ChinaRenJi Hospital
Jul 18, 2022
Immunoglobulin E-Mediated Food Allergy, Immunoglobulin G4-Related Disease, Symptoms and Signs Trial in Madrid (Food-specific
Recruiting
- Immunoglobulin E-Mediated Food Allergy
- +3 more
- Food-specific Immunoglobulin G4 and/or Immunoglobulin E antibody reactions
-
Madrid, SpainUniversidad Politécnica de Madrid
Jan 3, 2023
Immunoglobulin G Subclass 4 Related Disease, IgG4-related Disease, Autoimmune Pancreatitis Trial in Rochester (Rituximab,
Completed
- Immunoglobulin G Subclass 4 Related Disease
- +4 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jul 3, 2019
Neuromyelitis Optica Spectrum Disorder Trial in Beijing (Orelabrutinib)
Not yet recruiting
- Neuromyelitis Optica Spectrum Disorder
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital, Chinese Academy of Medica
Mar 16, 2022
Natural History of Eye Diseases Related to ABCA4 Mutations
Active, not recruiting
- Retinal Degeneration
- ABCA4-Related Retinopathies
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Interleukins in Periodontal Disease Progression
Recruiting
- Periodontitis
- Gingivitis
- Flow Cytometric Detection of Regulatory T Cells and Cytokines analysis by ELISA
-
Assiut, Asyut, EgyptDepartment of oral medicine, Periodontology, Oral diagnosis and
Nov 16, 2023
Autosomal Dominant Polycystic Kidney Disease Trial in Rochester
Recruiting
- Autosomal Dominant Polycystic Kidney Disease
-
Rochester, MinnesotaMayo Clinic
Aug 15, 2022
Frailty, Cognitive Function and Health-related Quality of Life
Active, not recruiting
- CKD Stage 4
- +3 more
-
Iasi, RomaniaUniversity of Medicine and Pharmacy "Grigore T. Popa"
Jan 21, 2023
Recurrent ALK Positive Large B-Cell Lymphoma, Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between
Not yet recruiting
- Recurrent ALK Positive Large B-Cell Lymphoma
- +28 more
- Biospecimen Collection
- +5 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Aug 17, 2022